by MM360 Staff | Apr 21, 2025 | Myeloma News
Source: Pharmacy Times articles Delayed pegaspargase reduces hepatotoxicity without affecting outcomes. Read More
by MM360 Staff | Apr 21, 2025 | Myeloma News
Source: Pharmacy Times articles Traditional risk factors were more contributable to cryptogenic ischemic stroke (CIS) without patent foramen ovale (PFO), whereas nontraditional ones were more critical for CIS with PFO. Read More
by MM360 Staff | Apr 21, 2025 | Myeloma News
Source: Pharmacy Times articles Children who received antibiotics between birth and 2 years of age were more likely to develop food allergies, allergic rhinitis, and asthma, but not neurodevelopmental conditions. Read More
by MM360 Staff | Apr 21, 2025 | Myeloma News
Source: Pharmacy Times articles By implementing work practices alongside administrative and engineering controls, a safe and healthy work environment can be achieved. Read More
by MM360 Staff | Apr 21, 2025 | Myeloma News
Source: Pharmacy Times articles Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discusses concerns about the implementation of the MDPNP. Read More
by MM360 Staff | Apr 21, 2025 | Myeloma News
Source: Pharmacy Times articles In contrast to the study findings, the prescribing information for cefiderocol lists different common adverse effects. Read More